Human cytomegalovirus vaccination: progress and perspectives of recombinant gB
A vaccine for Human cytomegalovirus (HCMV) remains a high priority as complications following infection are observed in immunocompromised individuals and in congenitally infected neonates. Numerous preclinical and clinical studies have investigated vaccine strategies ranging from live attenuated pre...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Future Medicine
2016
|
| Subjects: | |
| Online Access: | https://repository.londonmet.ac.uk/1240/1/FutVirol_2016.pdf |